Shape effect in the design of nanowire-coated microparticles as transepithelial drug delivery devices.
暂无分享,去创建一个
Vuk Uskoković | T. Desai | V. Uskoković | Kunwoo Lee | K. Fischer | Tejal A. Desai | Phin Peng Lee | Kathleen E. Fischer | Kunwoo Lee | P. Lee
[1] S. Tanabe,et al. The casein peptide Asn-Pro-Trp-Asp-Gln enforces the intestinal tight junction partly by increasing occludin expression in Caco-2 cells , 2010, British Journal of Nutrition.
[2] P. Claude. Morphological factors influencing transepithelial permeability: A model for the resistance of theZonula Occludens , 1978, The Journal of Membrane Biology.
[3] C. Weber,et al. Tight junction pore and leak pathways: a dynamic duo. , 2011, Annual review of physiology.
[4] Hsing-Wen Sung,et al. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. , 2011, Biomaterials.
[5] C. Lehr,et al. Propidium iodide labeling of nanoparticles as a novel tool for the quantification of cellular binding and uptake. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[6] Mauro Ferrari,et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[7] H. Santos,et al. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. , 2011, Biomaterials.
[8] C. Weber,et al. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function , 2010, Proceedings of the National Academy of Sciences.
[9] Tejal A Desai,et al. Microtextured substrata alter gene expression, protein localization and the shape of cardiac myocytes. , 2003, Biomaterials.
[10] Thomas J. Raub,et al. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.
[11] Tejal A Desai,et al. Gastrointestinal patch systems for oral drug delivery. , 2005, Drug discovery today.
[12] T. Desai,et al. Hierarchical nanoengineered surfaces for enhanced cytoadhesion and drug delivery. , 2011, Biomaterials.
[13] B. Powell,et al. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins , 2005, FEBS letters.
[14] Thomas Kissel,et al. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[15] K. Yagi,et al. Peptides as tight junction modulators. , 2011, Current pharmaceutical design.
[16] T. Desai,et al. Microfabricated drug delivery systems: from particles to pores. , 2003, Advanced drug delivery reviews.
[17] J. Madara,et al. Partitioning of paracellular conductance along the ileal crypt-villus axis: A hypothesis based on structural analysis with detailed consideration of tight junction structure-function relationships , 2005, The Journal of Membrane Biology.
[18] T. Desai,et al. Nanoengineered surfaces enhance drug loading and adhesion. , 2011, Nano letters.
[19] Jin-jin Fan,et al. Altered tight junctions and fence function in NRK-52E cells induced by aristolochic acid , 2012, Human & experimental toxicology.
[20] Tejal A Desai,et al. Biomimetic nanowire coatings for next generation adhesive drug delivery systems. , 2009, Nano letters.
[21] Deying Cao,et al. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[22] F. Veiga,et al. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems. , 2007, Nanomedicine.
[23] Tejal A Desai,et al. Contractility-dependent modulation of cell proliferation and adhesion by microscale topographical cues. , 2008, Small.
[24] T. Kissel,et al. Variation of peptide transporter (PepT1 and HPT1) expression in Caco-2 cells as a function of cell origin. , 2004, Journal of pharmaceutical sciences.
[25] Mauro Ferrari,et al. Design of bio-mimetic particles with enhanced vascular interaction. , 2009, Journal of biomechanics.
[26] J. Morris,et al. Macrophages increase microparticle uptake by enterocyte‐like Caco‐2 cell monolayers , 2010, Journal of anatomy.
[27] P. Augustijns,et al. Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2. , 2003, Journal of pharmaceutical sciences.
[28] R. Rao,et al. Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. , 2002, The Biochemical journal.
[29] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[30] V. Uskoković. Composites comprising cholesterol and carboxymethyl cellulose. , 2008, Colloids and surfaces. B, Biointerfaces.
[31] T. Orfeo,et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.
[32] H. Costantino,et al. Discovery of tight junction modulators: significance for drug development and delivery. , 2008, Drug discovery today.
[33] A. Basit. Advances in Colonic Drug Delivery , 2012, Drugs.
[34] Desirée Teijeiro-Osorio,et al. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. , 2009, Biomacromolecules.
[35] S. O'Sullivan,et al. Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability , 2010, Journal of Pharmacology and Experimental Therapeutics.
[36] Tejal A Desai,et al. PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. , 2012, Biomaterials.
[37] Kristy M Ainslie,et al. In vitro immunogenicity of silicon-based micro- and nanostructured surfaces. , 2008, ACS nano.
[38] Yahya E Choonara,et al. Diverse approaches for the enhancement of oral drug bioavailability , 2011, Biopharmaceutics & drug disposition.
[39] V. Uskoković. Insights into morphological nature of precipitation of cholesterol , 2008, Steroids.
[40] S. Chong,et al. Cell culture-based models for intestinal permeability: a critique. , 2005, Drug discovery today.
[41] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[42] Hsing-Wen Sung,et al. A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. , 2011, Biomaterials.